Related Experiment Video
Updated: Jun 29, 2025

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Intestinal microbiota and biliary system diseases.
Hua Wang1, Junfeng Gong2, Jingyi Chen3
1Department of Health, The Chinese People's Armed Police Forces Anhui Provincial Corps Hospital, Hefei, China.
Changes in gut bacteria are linked to biliary diseases like gallstones and cancer. This study highlights specific bacterial shifts, offering potential biomarkers for early diagnosis and new treatment directions for these growing health concerns.
Area of Science:
- Gastroenterology
- Microbiology
- Oncology
Background:
- Biliary system diseases are increasing globally, posing a significant health burden.
- The exact causes and mechanisms of these diseases remain largely unknown.
- Intestinal microbiota plays a role in bile duct lipid metabolism, influencing biliary health.
Purpose of the Study:
- To systematically review and compare changes in intestinal microbiota across various biliary diseases.
- To identify potential microbial biomarkers for early diagnosis of biliary conditions.
- To explore novel therapeutic strategies targeting the gut microbiome for biliary diseases.
Main Methods:
- Systematic literature review of studies up to November 2023.
- Searched databases: PubMed, Embase, and Web of Science.
- Focused on intestinal microbiota in gallstones (GS), non-calculous biliary inflammation, and biliary tract cancer (BTC).
Main Results:
- Decreased abundance of Faecalibacterium genus observed in GS, primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC), and BTC.
- Increased abundance of Veillonella, Lactobacillus, Streptococcus, and Enterococcus genera in PSC, PBC, and BTC.
- Variable changes in Clostridium genus abundance across different biliary diseases (reduced in GS, PBC, BTC; increased in PSC).
Conclusions:
- Significant alterations in intestinal microbiota composition are associated with various biliary diseases.
- Specific bacterial genera show potential as biomarkers for early detection of biliary system diseases.
- Understanding these microbial shifts offers new avenues for developing targeted therapies for biliary conditions.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Other Disorders of Digestive System
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

